Drug Profile


Alternative Names: Cerazette; ORG 2969

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Organon
  • Class Hormonal contraceptives; Norpregnenes; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Contraception

Most Recent Events

  • 03 Feb 2015 Launched prior to this date for Contraception/Pregnancy (Prevention) in Austria, Denmark, Finland, Hungary, Ireland, Italy, Poland, Portugal, Sweden, Czech Republic, France, Greece, Switzerland, Norway, Turkey, Argentina, Chile, Mexico, Venezuela, Brazil, New Zealand, Malaysia, the Philippines, Thailand, Indonesia, Israel, Russia, Ukraine, Hong Kong and India (PO)
  • 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
  • 30 Jun 2004 European regulatory authorities have approved the extension of missed pill window for desogestrel
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top